CD36 Contributes to Malaria Parasite-Induced Pro-Inflammatory Cytokine Production and NK and T Cell Activation by Dendritic Cells

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Gowda, Nagaraj M ^a   Wu, Xianzhu ^a   Kumar, Sanjeev ^a   Febbraio, Maria ^b   Gowda, D Channe ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INTERNALIZATION; MALARIA FALCIPARUM; MOUSE; NATURAL KILLER CELL; NONHUMAN; PARASITE IMMUNITY; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ANIMALS; ANTIGENS, CD36; CHO CELLS; CRICETULUS; CYTOKINES; DENDRITIC CELLS; HUMANS; INFLAMMATION; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALARIA, FALCIPARUM; MICE; MICE, INBRED C57BL; PARASITES; PLASMODIUM FALCIPARUM; T-LYMPHOCYTES;

EID: 84886637758     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077604     Document Type: Article

References (62)

1. Gething PW, Patil AP, Smith DL, Guerra CA, Elyazar IR, et al. (2011) A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J 10: 378.
2. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI, (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434: 214-217.
3. Guerra CA, Gikandi PW, Tatem AJ, Noor AM, Smith DL, et al. (2008) The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med 5: e38.
4. Van Der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE, (2006) A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol 22: 503-508.
5. Beeson JG, Brown GV, (2002) Pathogenesis of Plasmodium falciparum malaria: the roles of parasite adhesion and antigenic variation. Cell Mol Life Sci 59: 258-271.
6. Brabin BJ, Romagosa C, Abdelgalil S, Menendez C, Verhoeff FH, et al. (2004) The sick placenta - the role of malaria. Placenta 25: 359-378.
7. Baruch DI, Gormely JA, Ma C, Howard RJ, Pasloske BL, (1996) Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and ICAM 1. Proc Natl Acad Sci USA 93: 3497-5302.
8. Heddini A, Pettersson F, Kai O, Shafi J, Obiero J, et al. (2001) Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors. Infect Immun 69: 5849-5856.
9. Barnwell JW, Asch AS, Nachman RL, Yamaya M, Aikawa M, et al. (1989) A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. J Clin Invest 84: 765-772.
10. Buffet PA, Gamain B, Scheidig C, Baruch D, Smith JD, et al. (1999) Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: a receptor for human placental infection. Proc Natl Acad Sci USA 96: 12743-12748.
11. Ockenhouse CF, Tegoshi T, Maeno Y, Benjamin C, Ho M, et al. (1992) Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: Roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med 176: 1183-1189.
12. Senczuk AM, Reeder JC, Kosmala MM, Ho M, (2001) Plasmodium falciparum erythrocyte membrane protein 1 functions as a ligand for P-selectin. Blood 98: 3132-3125.
13. Fried M, Duffy PE, (1996) Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 271: 1502-1504.
14. Deitsch KW, Hviid L, (2004) Variant surface antigens, virulence genes and the pathogenesis of malaria. Trends Parasitol 20: 562-566.
15. Rowe JA, Claessens A, Corrigan RA, Arman M, (2009) Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. Expert Rev Mol Med 11: e16.
16. Janes JH, Wang CP, Levin-Edens E, Vigan-Womas I, Guillotte M, et al. (2011) Investigating the host binding signature on the Plasmodium falciparum PfEMP1 protein family. PLoS Patho 7: e1002032.
17. Franke-Fayard B, Janse CJ, Cunha-Rodrigues M, Ramesar J, Büscher P, et al. (2005) Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc Natl Acad Sci USA 102: 11468-11473.
18. El Khoury JB, Moore KJ, Means TK, Leung J, Terada K, et al. (2003) CD36 mediates the innate host response to β-amyloid. J Exp Med 97: 1657-1666.
19. Febbraio M, Hajjar DP, Silverstein RL, (2001) CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108: 785-791.
20. Erdman LK, Cosio G, Helmers AJ, Gowda DC, Grinstein S, et al. (2009) CD36 and TLR interactions in inflammation and phagocytosis: implications for malaria. J Immunol 183: 6452-6459.
21. Patel SN, Serghides L, Smith TG, Febbraio M, Silverstein RL, et al. (2004) CD36 mediates the phagocytosis of Plasmodium falciparum-infected erythrocytes by rodent macrophages. J Infect Dis 189: 204-213.
22. Patel SN, Lu Z, Ayi K, Serghides L, Gowda DC, et al. (2007) Disruption of CD36 impairs cytokine response to Plasmodium falciparum glycosylphosphatidylinositol and confers susceptibility to severe and fatal malaria in vivo. J Immunol 178: 3954-3961.
23. Ochola LB, Siddondo BR, Ocholla H, Nkya S, Kimani EN, et al. (2011) Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome. PLoS One 6: e14741.
24. Omi K, Ohashi J, Naka I, Patarapotikul J, Hananantachai H, et al. (2002) Polymorphisms of CD36 in Thai malaria patients. Southeast Asian J Trop Med Public Health 33: 1-4.
25. Omi K, Ohashi J, Patarapotikul J, Hananantachai H, Naka I, et al. (2003) CD36 polymorphism is associated with protection from cerebral malaria. Am J Hum Genet 72: 64-74.
26. Aitman TJ, Cooper LD, Norsworthy PJ, Wahid FN, Gray JK, et al. (2000) Malaria susceptibility and CD36 mutation. Nature 405: 1015-1016.
27. Pain A, Urban BC, Kai O, Casals-Pascual C, Shafi J, et al. (2001) A non-sense mutation in Cd36 gene is associated with protection from severe malaria. Lancet 357: 1502-1503.
28. Urban BC, Willcox N, Roberts DJ, (2001) A role for CD36 in the regulation of dendritic cell function. Proc Natl Acad Sci USA 98: 8750-8755.
29. Elliott SR, Spurck TP, Dodin JM, Maier AG, Voss TS, et al. (2007) Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1. Infect Immun 75: 3621-3632.
30. Schwarzer E, Turrini F, Ulliers D, Giribaldi G, Ginsburg H, et al. (1992) Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment. J Exp Med 176: 1033-1041.
31. Leitner WW, Krzych U, (1997) Plasmodium falciparum malaria blood stage parasites preferentially inhibit macrophages with high phagocytic activity. Parasite Immunol 19: 103-110.
32. Wu X, Gowda NM, Kumar S, Gowda DC, (2010) Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses. J Immunol 184: 4338-4348.
33. Pichyangkul S, Yongvanitchit K, Kum-arb U, Hemmi H, Akira S, et al. (2004) Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J Immunol 172: 4926-4933.
34. Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, et al. (2005) Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med 201: 19-25.
35. Parroche P, Lauw FN, Goutagny N, Latz E, Monks BG, et al. (2007) Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to toll-like receptor 9. Proc Natl Acad Sci USA 104: 1919-1924.
36. Seixas E, Cross C, Quin S, Langhorne J, (2001) Direct activation of dendritic cells by the malaria parasite, Plasmodium chabaudi chabaudi. Eur J Immunol 31: 2970-2978.
37. Newman KC, Korbel DS, Hafalla JC, Riley EM, (2006) Cross-talk with myeloid accessory cells regulates human natural killer cell interferon-γ responses to malaria. PLoS Patho 2: e118.
38. Langhorne J, Albano FR, Hensmann M, Sanni L, Cadman E, et al. (2004) Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection. Immunol Rev 201: 35-47.
39. Gowda NM, Wu X, Gowda DC, (2012) TLR9 and MyD88 are crucial for the development of protective immunity to malaria. J Immunol 188: 5073-5085.
40. Banchereau J, Steinman RM, (1998) Dendritic cells and the control of immunity. Nature 392: 245-252.
41. Steinman RM, Hemmi H, (2006) Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 311: 17-58.
42. Mach N, Gillessen S, Wilson SB, Sheehan C, Mihm M, et al. (2000) Differences in Dendritic Cells Stimulated in vivo by Tumors Engineered to Secrete Granulocyte-Macrophage Colony-stimulating Factor or Flt3-Ligand. Cancer Res. 60: 3239-3246.
43. Alkhalil A, Achur RN, Valiyaveettil M, Ockenhouse CF, Gowda DC, (2000) Structural requirements for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate proteoglycans of human placenta. J Biol Chem 275: 40357-40364.
44. Muthusamy A, Achur RN, Valiyaveettil M, Botti JJ, Taylor DW, et al. (2007) Chondroitin sulfate proteoglycan but not hyaluronic acid is the receptor for the adherence of Plasmodium falciparum-infected erythrocytes in human placenta and IRBC adherence upregulates the receptor expression. Am J Pathol 170: 1989-2000.
45. Brasel K, De Smedt T, Smith JL, Maliszewski CR, (2000) Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 96: 3029-3039.
46. Zhu J, Wu X, Goel S, Gowda NM, Kumar S, et al. (2009) MAPK-activated protein kinase 2 differentially regulates Plasmodium falciparum glycosylphosphatidylinositol-induced production of tumor necrosis factor-α and interleukin-12 in macrophages. J Biol Chem 284: 15750-15761.
47. Gowda NM, Wu X, Gowda DC, (2011) The nucleosome (histone-DNA complex) is the TLR9-specific immunostimulatory component of Plasmodium falciparum that activates DCs. PLoS One 6: e20398.
48. Edwards AD, Diebold SS, Slack EM, Tomizawa H, Hemmi H, et al. (2003) Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8α+ DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 33: 827-833.
49. Krieg AM, (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20: 709-760.
50. Wagner H, (2004) The immunobiology of the TLR9 subfamily. Trends Immunol 25: 381-386.
51. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, et al. (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168: 4531-4537.
52. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, et al. (2002) Characterization of human blood dendritic cell subsets. Blood 100: 4512-4520.
53. Huang MM, Bolen JB, Barnwell JW, Shattil SJ, Brugge JS, (1991) Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc Natl Acad Sci USA 88: 7844-7848.
54. Yipp BG, Robbins SM, Resek ME, Baruch DI, Looareesuwan S, et al. (2003) Src-family kinase signaling modulates the adhesion of Plasmodium falciparum on human microvascular endothelium under flow. Blood 101: 2850-2857.
55. Chen K, Febbraio M, Li W, Silverstein RL, (2008) A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein. Circ Res 102: 1512-1519.
56. Davis SP, Amrein M, Gillrie MR, Lee K, Muruve DA, et al. (2012) Plasmodium falciparum-induced CD36 clustering rapidly strengthens cytoadherence via p130CAS-mediated actin cytoskeletal rearrangement. FASEB J 26: 1119-1130.
57. Silverstein RL, Febbraio M, (2009) CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2: re3.
58. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, et al. (2005) CD36 is a sensor of diacylglycerides. Nature 433: 523-527.
59. Diallo TO, Remoue F, Gaayeb L, Schacht AM, Charrier N, et al. (2010) Schistosomiasis coinfection in children influences acquired immune response against Plasmodium falciparum malaria antigens. PLoS One 5: e12764.
60. Fesel C, Goulart LF, Silva Neto A, Coelho A, Fontes CJ, et al. (2005) Increased polyclonal immunoglobulin reactivity toward human and bacterial proteins is associated with clinical protection in human Plasmodium infection. Malar J 4: 5.
61. Ned RM, Price AE, Crawford SB, Ayisi JG, van Eijk AM, et al. (2008) Effect of placental malaria and HIV infection on the antibody responses to Plasmodium falciparum in infants. J Infect Dis 198: 1609-1619.
62. Su Z, Segura M, Morgan K, Loredo-Osti JC, Stevenson MM, (2005) Impairment of protective immunity to blood-stage malaria by concurrent nematode infection. Infect Immun 73: 3531-3539.